Willow Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 05 Sep 24 | BuyUS$3,697 | Chris Savile | Individual | 50,000 | US$0.074 | |
| 14 Aug 24 | BuyUS$3,071 | Travis Doupe | Individual | 49,500 | US$0.062 | |
| 18 Jul 24 | BuyUS$21,904 | Travis Doupe | Individual | 300,000 | US$0.073 | |
| 18 Jul 24 | BuyUS$21,904 | Donald Archibald | Individual | 300,000 | US$0.073 | |
| 18 Jul 24 | BuyUS$21,904 | James Lalonde | Individual | 300,000 | US$0.073 | |
| 18 Jul 24 | BuyUS$21,904 | Chris Savile | Individual | 300,000 | US$0.073 | |
| 18 Jul 24 | BuyUS$21,904 | Trish Choudhary | Individual | 300,000 | US$0.073 | |
| 09 Jan 24 | BuyUS$4,966 | Trish Choudhary | Individual | 70,000 | US$0.071 | |
| 29 Nov 23 | BuyUS$2,755 | Chris Savile | Individual | 50,000 | US$0.055 |
Insider Trading Volume
Insider Buying: CANS.F insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 150,000 | 0.104% |
| Individual Insiders | 6,063,817 | 4.21% |
| VC/PE Firms | 26,048,476 | 18.1% |
| General Public | 111,941,900 | 77.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.1%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 26,048,476 | US$1.5m | 0% | 76.08% | |||
| 1,868,335 | US$106.9k | 23.5% | no data | |||
| 1,546,284 | US$88.5k | 36.5% | no data | |||
| 1,362,313 | US$77.9k | 42.4% | no data | |||
| 822,798 | US$47.1k | 76.1% | no data | |||
| 386,498 | US$22.1k | 1,150% | no data | |||
| 150,000 | US$8.6k | 0% | no data | |||
| 70,922 | US$4.1k | 0% | no data | |||
| 6,667 | US$381.2 | 0% | no data |